Short-course Radiotherapy Combined With Retlirafusp Alfa and CAPOX Chemotherapy as Neoadjuvant Therapy for Locally Advanced Rectal Cancer: A Prospective, Single-arm, Phase II Clinical Study
Clinical trial NCT07663071 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07663071
- Sponsor
- Harbin Medical University
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-27
- Primary completion
- 2028-05-27
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.